Grafted neural stem cells migrate to substantia nigra and improve behavior in Parkinsonian rats

Neuroscience Letters

Volumn 462, Issue 3, 2009, Pages 213-218

  Zhu, Qing feng ^a   Ma, Ji ^a   Yu, Ling li ^a   Yuan, Chong gang ^a  

^a EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

Migration; Neural stem cells; Parkinson's disease; Transplantation

Indexed keywords

TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL SURVIVAL; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; MALE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; SUBVENTRICULAR ZONE;

ANIMALS; MALE; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; STEM CELLS; STEREOTYPED BEHAVIOR; SUBSTANTIA NIGRA;

EID: 67849106231     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.07.008     Document Type: Article

References (24)

1. Akerud P., Canals J.M., Snyder E.Y., and Arenas E. Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. J. Neurosci. 21 (2001) 8108-8118
2. Bjugstad K.B., Redmond Jr. D.E., Teng Y.D., Elsworth J.D., Roth R.H., Blanchard B.C., Snyder E.Y., and Sladek Jr. J.R. Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: a return to control measures. Cell Transplant. 14 (2005) 183-192
3. Bjugstad K.B., Teng Y.D., Redmond Jr. D.E., Elsworth J.D., Roth R.H., Cornelius S.K., Snyder E.Y., and Sladek Jr. J.R. Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease. Exp. Neurol. 211 (2008) 362-369
4. Brederlau A., Correia A.S., Anisimov S.V., Elmi M., Paul G., Roybon L., Morizane A., Bergquist F., Riebe I., Nannmark U., Carta M., Hanse E., Takahashi J., Sasai Y., Funa K., Brundin P., Eriksson P.S., and Li J.Y. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 24 (2006) 1433-1440
5. Cao Q., Benton R.L., and Whittemore S.R. Stem cell repair of central nervous system injury. J. Neurosci. Res. 68 (2002) 501-510
6. Dimayuga F.O., Ding Q., Keller J.N., Marchionni M.A., Seroogy K.B., and Bruce-Keller A.J. The neuregulin GGF2 attenuates free radical release from activated microglial cells. J. Neuroimmunol. 136 (2003) 67-74
7. Imitola J., Raddassi K., Park K.I., Mueller F.J., Nieto M., Teng Y.D., Frenkel D., Li J., Sidman R.L., Walsh C.A., Snyder E.Y., and Khoury S.J. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 18117-18122
8. Jankovic J., and Aguilar L.G. Current approaches to the treatment of Parkinson's disease. Neuropsychiatr. Dis. Treat. 4 (2008) 743-757
9. Kim J.H., Auerbach J.M., Rodríguez-Gómez J.A., Velasco I., Gavin D., Lumelsky N., Lee S.H., Nguyen J., Sánchez-Pernaute R., Bankiewicz K., and McKay R. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418 (2002) 50-56
10. Kim S.U., Park I.H., Kim T.H., Kim K.S., Choi H.B., Hong S.H., Bang J.H., Lee M.A., Joo I.S., Lee C.S., and Kim Y.S. Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease. Neuropathology 26 (2006) 129-140
11. Kim S.U. Genetically engineered human neural stem cells for brain repair in neurological diseases. Brain Dev. 29 (2007) 193-201
12. Kuan W.L., and Barker R.A. New therapeutic approaches to Parkinson's disease including neural transplants. Neurorehab. Neural Repair 19 (2005) 155-181
13. Lotharius J., and Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci. 3 (2002) 932-942
14. Meissner K.K., Kirkham D.L., and Doering L.C. Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's. Brain Res. 1057 (2005) 105-112
15. Mendez I., Vinuela A., Astradsson A., Mukhida K., Hallett P., Robertson H., Tierney T., Holness R., Dagher A., Trojanowski J.Q., and Isacson O. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat. Med. 14 (2008) 507-509
16. Morizane A., Li J.Y., and Brundin P. From bench to bed: the potential of stem cells for the treatment of Parkinson's disease. Cell Tissue Res. 331 (2008) 323-336
17. Mueller F.J., Serobyan N., Schraufstatter I.U., DiScipio R., Wakeman D., Loring J.F., Snyder E.Y., and Khaldoyanidi S.K. Adhesive inter actions between human neural stem cells and inflamed human vascular endothelium are mediated by integrins. Stem Cells 24 (2006) 2367-2372
18. Müller F.J., Snyder E.Y., and Loring J.F. Gene therapy: can neural stem cells deliver?. Nat. Rev. Neurosci. 7 (2006) 75-84
19. Redmond Jr. D.E., Bjugstad K.B., Teng Y.D., Ourednik V., Ourednik J., Wakeman D.R., Parsons X.H., Gonzalez R., Blanchard B.C., Kim S.U., Gu Z., Lipton S.A., Markakis E.A., Roth R.H., Elsworth J.D., Sladek Jr. J.R., Sidman R.L., and Snyder E.Y. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 11869-11870
20. Ryu M.Y., Lee M.A., Ahn Y.H., Kim K.S., Yoon S.H., Snyder E.Y., Cho K.G., and Kim S.U. Brain transplantation of neural stem cells cotransduced with tyrosine hydroxylase and GTP cyclohydrolase 1 in parkinsonian rats. Cell Transplant. 14 (2005) 193-202
21. Sofroniew M.V., Howe C.L., and Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24 (2001) 1217-1281
22. Takeuchi H., Natsume A., Wakabayashi T., Aoshima C., Shimato S., Ito M., Ishii J., Maeda Y., Hara M., Kim S.U., and Yoshida J. Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGF-dependent manner. Neurosci. Lett. 426 (2007) 69-74
23. Timmer M., Grosskreutz J., Schlesinger F., Krampfl K., Wesemann M., Just L., Bufler J., and Grothe C. Dopaminergic properties and function after grafting of attached neural precursor cultures. Neurobiol. Dis. 21 (2006) 587-606
24. Yasuhara T., Matsukawa N., Hara K., Yu G., Xu L., Maki M., Kim S.U., and Borlongan C.V. Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. J. Neurosci. 26 (2006) 12497-12511